Community/Retail

Study seeks to determine how HIV avoids the zinc-finger antiviral protein and how it binds the RNA.

There are some basic tips or tricks to getting the most out of your insurance plan and to maintain the care patients are accustomed to.

The CDC has reported 34800 new cancer diagnoses linked to HPV annually, and the virus is predicted to account for more than 90% of all cervical and anal cancers, more than 60% of all penile cancers, and 70% of all oral cancers.

Members of the former International Academy of Compounding Pharmacists voted in November 2019 to change the association’s name to the Alliance for Pharmacy Compounding.

The Prescription Drug User Fee Act date, the FDA action data for this supplemental application, is scheduled for the second quarter of 2020.

Annoying work habits can set the tone for lower productivity and teamwork in the pharmacy.

The treatment is the first and only fast-acting mealtime insulin injection that does not have a pre-meal dosing recommendation, according to Novo Nordisk.

Could tadalafil be causing a patient to feel dizzy?

At the recent ASHP (American Society of Health-System Pharmacists) Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada, 3 speakers discussed new developments in influenza management.

The bill would have given the state's superintendent of insurance licensing and regulatory authority over pharmacy benefit managers (PBMs).1

Novadoz Pharmaceuticals, who markets the product, has commenced shipping of the drug, available in bottles of 30 tablets.

From newsworthy moments to groundbreaking research, these are the most popular articles published on Pharmacy Times® during 2019.

Officials with the FDA have approved Eisai’s lemborexant (Dayvigo) 5 mg and 10 mg for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.

Officials with the FDA have approved Intra-Cellular Therapies’ lumateperone (Caplyta) for the treatment of schizophrenia in adults, according to the company.

What classic Christmas movie character fits best with your pharmacy profession?

The applications for the first generics of apixaban (Eliquis, Bristol-Meyers Squibb) tablets were approved to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation

Ubrogepant is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved by the agency for the acute treatment of migraine.

Tazarotene is the first acne treatment to be available in a lotion form, showing strong efficacy with favorable tolerability.

Take care of yourself by providing your body with nutrients that support overall health, your immune system, mood and energy metabolism.

Inflammation from beta blockers is caused by a cellular process known as autophagy.

Research has been conducted to produce a vaccination that gives patients long-lasting protection from influenza.

Jelly of the Month might not have impressed Clark Griswold, but we're sure there's a pharmacist on your gift list that would appreciate one of these items.

Approximately 2 out of 6 study participants tested positive after vaping cannabis that contained 0.39% THC using urine testing methods.

The CDC reported progress with the current status of the 3 strategies within the national initiative, Ending the HIV Epidemic: A Plan for America.

What is causing a patient’s memory loss?

Icosapent ethyl is the first FDA-approved prescription form of fish oil to reduce cardiovascular risk among patients with triglyceride levels as an add-on to maximally tolerated statin therapy.

The Trend Report is a synthesis of multiple research projects exploring risk factors that influence medication adherence, along with background and implications.

A report suggests that addressing financial barriers to antiretroviral therapy adherence may improve levels of viral suppression.

More men than women initiate kidney replacement therapy despite a higher prevalence of chronic kidney disease seen in women.

The FDA has approved the Unidose Liquid System (AptarGroup Inc) as the first and only nasal rescue treatment for acute repetitive seizures in patients with epilepsy.